NDC 62993-0002-05 - Docusate Sodium and Sennosides
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 62993-0002
- Requested NDC
- 62993-0002-05
- Package NDCs from labels
- 62993-0002-1, 62993-0002-2, 62993-0002-3, 62993-0002-4, 62993-0002-5, 62993-0002-05
- Manufacturer
- Morepen Laboratories Limited
- Effective date
- 2026-01-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Docusate Sodium and Sennosides - Morepen Laboratories Limited | Morepen Laboratories Limited | 2026-01-23 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62993-0002-1 | Docusate Sodium and Sennosides | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 62993-0002-2 | Docusate Sodium and Sennosides | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 62993-0002-3 | Docusate Sodium and Sennosides | 100 in 1 BOTTLE | TABLET | 100 | 2 | |
| 62993-0002-4 | Docusate Sodium and Sennosides | 1000 in 1 BOTTLE | TABLET | 1000 | 2 | |
| 62993-0002-5 | Docusate Sodium and Sennosides | 3000 in 1 BOTTLE | TABLET | 3000 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 62993-0002-1 | EA - Each | 62993-0002 | 8de5b6e7-78c1-4e96-a2e3-a59c7a547352 | 1 | 2026-05-22 |
| 62993-0002-2 | EA - Each | 62993-0002 | 34e7f982-0b62-47b0-b752-24bf6a12ee2a | 1 | 2026-05-22 |
| 62993-0002-3 | EA - Each | 62993-0002 | 4c536160-78d8-4adc-af74-9fdded62b065 | 1 | 2026-05-22 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HERA SILKYSTAY FOUNDATION 37W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4105f3-d08b-edb5-e063-6394a90ad28b | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 39N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f41120a-521a-f5ac-e063-6394a90ac021 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 41W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4158f0-c743-29c2-e063-6394a90ac721 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 43N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f41ecb2-9fe5-ade7-e063-6294a90abc4e | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 43O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f425415-ed84-fc33-e063-6394a90a15f7 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 44C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f42d960-6b86-b4cd-e063-6294a90a98f3 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 45N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4326fc-b3c3-1a8b-e063-6294a90a8d9b | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 45W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4335c8-596f-3269-e063-6294a90a6c3d | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 46W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f43404e-bdab-3f4b-e063-6294a90ab881 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 47N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f435148-dcb1-cfdf-e063-6394a90aa8b6 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 50N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f43610f-6c4f-dd9d-e063-6394a90ab60a | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 48N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4372c4-b87a-91ab-e063-6294a90a6807 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 49C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4380d1-2cf4-1fd8-e063-6394a90a0aa3 | 2026-11-01 | Warnings | 15FIX9V2JP |
| Gentle Laxative Stimulant Laxative | BISACODYL | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | bcd3c07d-bd83-4452-9736-35c85db30c15 | 2026-10-29 | Warnings | M007 |
| Quality Choice | CALCIUM POLYCARBOPHIL | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | f1e69c65-c1b0-459f-9a12-b1a92b90036b | 2026-10-29 | Warnings | M007 |
| CDMA Fiber Therapy | METHYLCELLULOSE | CHAIN DRUG MARKETING ASSOCIATION | 62bbcaf2-1d0c-485f-9159-685700aa3418 | 2026-10-29 | Warnings | M007 |
| citroma | MAGNESIUM CITRATE | Old East Main Co. | 51ed515b-cc51-4ea1-b612-090476135005 | 2026-10-29 | Warnings, Adverse reactions | M007 |
| HERA BLACK CUSHION FOUNDATION 13N1 | OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE | Amorepacific Corporation | 5aff3d25-d034-0815-e063-6294a90a8664 | 2026-10-29 | Warnings | 15FIX9V2JP |
| Quality Choice Fiber Laxative | PSYLLIUM HUSK | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 2ee637c4-c4c6-4a24-ae99-612205afd592 | 2026-10-29 | Warnings | M007 |
| Magnesium Citrate | EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 4 Visions LLC | 5eeb0d66-06c7-7789-e063-6394a90aaff4 | 2026-10-28 | Warnings | M007 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.